Literature DB >> 11148045

Activation of the insulin receptor's kinase domain changes the rate-determining step of substrate phosphorylation.

A J Ablooglu1, R A Kohanski.   

Abstract

The insulin receptor and many other protein kinases are activated by relief of intrasteric inhibition that is regulated by reversible phosphorylation. The changes accompanying activation of the insulin receptor's kinase domain were analyzed using steady-state kinetics, viscometric analysis, and equilibrium binding measurements. Peptide phosphorylation catalyzed by the unphosphorylated basal-state kinase is limited by a slow rate of the chemical step, and the activated enzyme is limited by product release rates. Underlying these changes were a 36-fold increase in the rate constant for the chemical step of the enzyme-catalyzed reaction, a 5-fold increase in the affinity for MgATP, and an 8-fold increase in the affinity for peptide substrate. This results in binding of substrates that is 2.2 kcal/mol more favorable and a free energy barrier for transition state formation that is lowered by 2.1 kcal/mol in the activated enzyme. Therefore, the change in conformational free energy inherent in the protein after autophosphorylation [Bishop, S. M., Ross, J. B. A., and Kohanski, R. A. (1999) Biochemistry 38, 3079-3089] is equally distributed between formation of the substrate ternary complex and formation of the transition state complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11148045     DOI: 10.1021/bi002292m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Trading the micro-world of combinatorial complexity for the macro-world of protein interaction domains.

Authors:  Nikolay M Borisov; Nick I Markevich; Jan B Hoek; Boris N Kholodenko
Journal:  Biosystems       Date:  2005-10-19       Impact factor: 1.973

2.  Signaling through receptors and scaffolds: independent interactions reduce combinatorial complexity.

Authors:  Nikolay M Borisov; Nick I Markevich; Jan B Hoek; Boris N Kholodenko
Journal:  Biophys J       Date:  2005-05-27       Impact factor: 4.033

3.  Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability.

Authors:  Anshuman Dixit; Ali Torkamani; Nicholas J Schork; Gennady Verkhivker
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

4.  Intrasteric inhibition of ATP binding is not required to prevent unregulated autophosphorylation or signaling by the insulin receptor.

Authors:  M Frankel; A J Ablooglu; J W Leone; E Rusinova; J B Ross; R L Heinrikson; R A Kohanski
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Nucleotide release sequences in the protein kinase SRPK1 accelerate substrate phosphorylation.

Authors:  Brandon E Aubol; Ryan M Plocinik; Maria L McGlone; Joseph A Adams
Journal:  Biochemistry       Date:  2012-08-09       Impact factor: 3.162

6.  The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations.

Authors:  Erin D Lew; Cristina M Furdui; Karen S Anderson; Joseph Schlessinger
Journal:  Sci Signal       Date:  2009-02-17       Impact factor: 8.192

7.  A computational study of the phosphorylation mechanism of the insulin receptor tyrosine kinase.

Authors:  Baojing Zhou; Chung F Wong
Journal:  J Phys Chem A       Date:  2009-04-30       Impact factor: 2.781

8.  Dynamic, structural and thermodynamic basis of insulin-like growth factor 1 kinase allostery mediated by activation loop phosphorylation.

Authors:  Yaozong Li; Kwangho Nam
Journal:  Chem Sci       Date:  2017-03-20       Impact factor: 9.825

9.  Bifurcation analysis of insulin regulated mTOR signalling pathway in cancer cells.

Authors:  Krishnamachari Sriram
Journal:  IET Syst Biol       Date:  2018-10       Impact factor: 1.615

Review 10.  Insulin signaling in health and disease.

Authors:  Alan R Saltiel
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.